The global blood transfusion diagnostics market was valued at USD 3.45 billion in 2019 and is expected to grow at a CAGR of 6.7% during the forecast period. The rising cases of organ transplantation and surgeries requiring transfusion increases the demand for donor screening are major factors driving market growth. Surge in prevalence of chronic disorders such as kidney problems, sickle cell anemia,血友病, and thrombocytopenia is also favoring the uptake of transfusion diagnosis.
输血诊断使从业者能够防止不同的等离子体所生风险的传播,如过敏反应,病毒感染,铁过载和溶血反应。及时诊断还检测乙型肝炎,C,艾滋病,梅毒和西尼罗病毒的存在。据全国性,肺和血液研究所,RBC计数的减少是最常见的疾病,由于铁的缺乏,大多数病例。因此,随着RBC输血的上升,对血液输血诊断的需求必将涉及见证生长。
Know more about this report:请求样本页面
成长司机
Increasing hospital admissions due to surgeries, road traffic accidents, blood-related disorders, trauma cases, and injuries due to recreational activities, led to significant demand in the transfusions, thus driving the global market. In addition, the increasing demand for blood transfusion for complex surgeries across the developed economies in North America and Europe is likely to complement market growth.
Increasing need for donor screening owing to the possibility of Transfusion-Transmitted Infections (TTIs) is expected to drive the demand for transfusion diagnostics across the regions. In addition, the growing road accidents have led to the rising demand for blood transfusion. According to WHO, around 20 to 50 million people suffer from non-fatal injuries with need for transfusion driving market growth.
The market is primarily segmented on the basis of product, application, end-use, and region.
By Product |
By Application |
By End Use |
By Region |
|
|
|
|
Know more about this report:请求样本页面
基于产品,血液输血诊断市场分为仪器,试剂和套件等。由于在筛选供体和受援样本方面的转移诊断重复使用,试剂和工具包占2019年最大的市场份额。本地和全球参与者在血液分组,供体筛查和试剂中易于提供的宽容产品组合也促进了节段增长。
此外,技术先进的供体血液筛查系统,例如Mosaiq,由分组和TTI供体样品筛查和Roche的COBAS 201自动化系统使用实时PCR技术,确保改善供体样品的血液筛查。
On the basis of application, the global market is segmented into blood grouping, and disease screening. The disease screening segment is expected to hold a majority revenue share and is projected to register highest growth over the forecast period. The routine blood typing and cross matching performed for the transfusion therapy is driving the segment’s share over the forecast period.
On the basis of end-use, the global blood transfusion diagnostics market is segmented into hospitals, blood banks, diagnostic laboratories, and others. Blood banks segment accounted for the largest revenue share in 2019 owing to large screening process being carried out before surgeries. Blood banks usually perform standard tests which include RBC antibody screening, infectious disease screening, Rh typing, and compatibility tests in between donor and recipient.
North America was the largest revenue contributor in 2019 to transfusion diagnostics on account of the presence of major key players in the country, people awareness regarding blood donations and associated disorders, presence of advanced healthcare infrastructure, and the availability of different assays to check donor compatibility.
Asia Pacific is projected to register highest growth rate over the forecast period. This increase is due to several government sponsored blood donation campaigns, especially in India and South Korea. However, China has been characterized with low donation rate, i.e., 1 donor per 100 populations, in 2016, which is well below to the world average of 3 to 4 donors per 100 populations. Despite, stricter laws of blood donation, there is a strong regional variation, posing difficulties for nationwide campaigns, which is likely to restraint market growth.
运营市场的一些主要球员包括Grifols S.A。Immucer Inc.;Ortho临床诊断;钻石诊断,雅培实验室;电力医疗技术,Bio-Rad Laboratories,Inc。;Diagnostica Stago,F. Hoffmann-La Roche Ltd;和额字有限公司公司专注于新产品开发和发布,例如,2019年9月,Roche收到了在公司的Cobas 6800/8800系统中使用的Cobas Babesia测试批准,以筛选筛选捐赠。